Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.030
+0.090 (4.64%)
At close: May 11, 2026, 4:00 PM EDT
2.050
+0.020 (0.99%)
After-hours: May 11, 2026, 7:43 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $199.47 million as of May 11, 2026. Its market cap has increased by 177.09% in one year.
Market Cap
199.47M
Enterprise Value
107.78M
1-Year Change
177.09%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $199.47M, a decrease of -77.55%. That is a compound annual growth rate of -26.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 199.47M | 34.22% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 212.27M |
| MediWound | 211.55M |
| Atrium Therapeutics | 205.57M |
| Precision BioSciences | 202.81M |
| Tonix Pharmaceuticals Holding | 200.44M |
| Karyopharm Therapeutics | 198.61M |
| Tiziana Life Sciences | 197.18M |
| Corbus Pharmaceuticals Holdings | 195.81M |